Antiepileptic drugs in development
- 1 December 2006
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 5 (12) , 1064-1067
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Diverse mechanisms of antiepileptic drugs in the development pipelineEpilepsy Research, 2006
- Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitroNeuropharmacology, 2006
- The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure modelEpilepsy Research, 2005
- Efficacy and Safety of Rufinamide Adjunctive Therapy in Patients with Lennox–Gastaut Syndrome (LGS): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel TrialNeurology, 2005
- The neurobiology of antiepileptic drugsNature Reviews Neuroscience, 2004
- M-current modulators alter rat spinal nociceptive transmission: an electrophysiological study in vitroNeuropharmacology, 2004
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- Ganaxolone: a novel positive allosteric modulator of the GABAA receptor complex for the treatment of epilepsyExpert Opinion on Investigational Drugs, 1999
- D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizuresEuropean Journal of Pharmacology, 1996
- D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizuresEpilepsy Research, 1996